A large number of patients in advanced stages of kidney disease are inappropriately being prescribed statins to lower their cholesterol, U.S. researchers say.

Lead author Ali Olyaei, a professor of pharmacotherapy in the College of Pharmacy at Oregon State University, said the review of multiple studies, raised serious questions about the value of the statins in kidney disease.

The cholesterol-lowering drugs offer patients with kidney disease no benefit and might increase other health risks such as diabetes, dementia or muscle pain, Olyaei said.



Freddie Allen is the National News Editor for the NNPA News Wire and BlackPressUSA.com. 200-plus Black newspapers. 20 million readers. You should follow Freddie on Twitter and Instagram @freddieallenjr.